NSEGeneral Updates24 Jun 2026 · 24 Jun 2026, 04:36 pm

General Updates

Sanofi India Limited · SANOFI

✦ AI SummaryRegulatory

Sanofi India Limited has informed the Exchange about disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding an order issued by Deputy Commissioner, State GST, Ahmedabad, Gujarat, rejecting the company's refund application for the period 2014-15 to 2017-18.

Analysis Scores

Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk6/10
Balance Sheet Risk1/10
Liquidity Impact1/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Sanofi India Limited has informed the Exchange about disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Attachments (1)

📄

COSECSANOFI_24062026163614_BSENSEUPLOAD.pdf

pdf

Download →
View document text
24th June 2026 The Secretary The Secretary BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers ExExchange Plaza, C-1, Block G, Dalal Street Bandra-Kurla Complex, Mumbai 400 001 Bandra (E), Mumbai 400 051 Scrip Code: 500674 Symbol: SANOFI Sub: Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (“SEBI (LODR) Regulations”) Dear Sir/Madam, In compliance with Regulation 30 of the SEBI (LODR) Regulations, we hereby submit the disclosure regarding Order issued by Deputy Commissioner, State GST, Ahmedabad, Gujarat. The details of the above Order as required under Regulation 30 of SEBI (LODR) Regulations are given below: Name of the authority Deputy Commissioner, State GST, Ahmedabad, Gujarat Nature and details of the Deputy Commissioner, State GST, Ahmedabad, action(s) taken, initiated or Gujarat, has rejected the refund application for the order(s) passed period 2014-15 to 2017-18 (till July 2017) for INR 11,62,853 filed by the Company on the ground that the refund claim arises on account of debit of Electronic Credit Ledger (‘ECL’) towards mandatory pre-deposit as required under Central Excise Act, 1944 and not as “tax” under the CGST Act, 2017 to be eligible for refund. Further, pre-deposit under Central Excise Act, 1944 comes within domain of Central GST and not State GST, hence the refund application before the State GST is not maintainable. Date of receipt of direction or Order received by the Company on 23rd June 2026 order, including any ad-interim or interim orders, or any other communication from the authority Details of the While filing of appeal under the Central Excise Act, violation(s)/contravention(s) 1944, for the period 2014-15 to 2017-18 (till June committed or alleged to be 2017), the Company had paid mandatory pre-deposit committed; by debiting ECL for INR 11,62,853. The Company had filed an application for refund of the mandatory pre- deposit before the State GST. However, the refund application has been rejected by the Deputy Commissioner, State GST, Ahmedabad, Gujarat, on the ground that pre-deposit was not paid as “tax” to Sanofi India Limited, Sanofi House, CTS No. 117-B, L&T Business Park, Saki Vihar Road, Powai, Mumbai 400 072 - India - Tel.: +91(22) 2803 2000 - Fax: +91(22) 2803 2939 Corporate Identity Number: L24239MH1956PLC009794 Website: www.sanofiindialtd.com | www.sanofi.in Email: igrc.sil@sanofi.com be eligible for refund under the CGST Act, 2017. Further the refund claim arises from Central Excise Act, 1944 which comes within domain of Central GST and not State GST, hence the refund application before the State GST is not maintainable. Impact on financial, operation The Company would file appeals before Appellate or other activities of the listed Authorities. entity, quantifiable in monetary terms to the extent possible. There is no material impact on financial, operational or other activities of the Company. This is for your information and records. Thanking you, Yours faithfully For Sanofi India Limited Haresh Vala Company Secretary and Compliance Officer Membership No.: A18246 Sanofi India Limited, Sanofi House, CTS No. 117-B, L&T Business Park, Saki Vihar Road, Powai, Mumbai 400 072 - India - Tel.: +91(22) 2803 2000 - Fax: +91(22) 2803 2939 Corporate Identity Number: L24239MH1956PLC009794 Website: www.sanofiindialtd.com | www.sanofi.in Email: igrc.sil@sanofi.com
Sanofi India Limited — General Updates | BazaarWatch